Tags : upamostat

COVID-19 Pharma

RedHill Biopharma Collaborates with NIAID to Investigate RHB-107 (upamostat, WX-671)

Shots: RedHill in collaboration with NIAID will evaluate RHB-107 in non-clinical studies to determine its activity against SARS-CoV-2. The agreement will facilitate the pre-clinical evaluation of RHB-107 as a treatment for COVID-19 Additionally, RedHill is evaluating opaganib (Yeliva, ABC294640) against COVID-19. On Apr 17, the company unveils about the compassionate use of Opaganib is underway […]Read More